While results from the Digital Mammographic Imaging Screening Trial (DMIST) trial, published in 2005, demonstrated that digital mammography outperformed conventional film-screen mammography for a large percentage of women,1 data from the Food and Drug Administration (FDA) show that the technology has only been adopted by 25% of the 8,000 imaging sites in the United States.2